Skip to main content

Latest SEC Filings — Page 95

Most recent SEC EDGAR filings across all covered tickers, sorted chronologically. Wiseek AI reads each filing and scores it 1–10 for market-moving potential; click through for full analysis.

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.

NAPCO FY2026 10-K: Record $202.3M Revenue, $16M Litigation Charge, and New CEO Employment Terms
Form 10-KNSSC · Form 10-K · 2026-08-24
NAPCO Posts Record Q4 Revenue of $55.8M and Raises Dividend 13.3% to $0.17
Form 8-KNSSC · Form 8-K · 2026-08-24
FDA Extends Deramiocel PDUFA Date to November 22, 2026 After Major Amendment
ProForm 8-KCAPR · Form 8-K · 2026-08-24
Braskem Board Approves Extrajudicial Reorganization for US$10.9B in Unsecured Debt
ProForm 6-KBAK · Form 6-K · 2026-08-24
Lion Group Reveals $15.8M HYPE Token Treasury
Form 6-KLGHL · Form 6-K · 2026-08-24
Utz Brands Files Full Financing Agreements for $2.9B Intersnack Take-Private
ProForm SC 13E3UTZ · Form SC 13E3 · 2026-08-24
Zillow Settles FTC Antitrust Suit, Keeps Redfin Partnership Through 2030
Form 8-KZG · Form 8-K · 2026-08-24
Robo.ai Swings to US$46.7M Net Income but Flags Going Concern Doubt
ProForm 6-KAIIO · Form 6-K · 2026-08-24
Ming Shing Amends $510M Acquisition Filing: Adds $515M Independent Valuation, No Fairness Opinion
ProForm 6-K/APMA · Form 6-K/A · 2026-08-24
Afya Confirms Early-Stage Merger Talks with Yduqs
ProForm 6-KAFYA · Form 6-K · 2026-08-24
Bitmine's Crypto Holdings Jump to $14.9B as ETH Reaches 5.85M Tokens
Form 8-KBMNR · Form 8-K · 2026-08-24
Expion360 Pivots to Oil & Gas: $9M Private Placement, $91M Investment Right, New CEO, and Name Change to Expion Energy
ProForm 8-KXPON · Form 8-K · 2026-08-24
USA Rare Earth Clears Key Merger Condition as U.S. Government Upsizes SPV Funding to $750M
ProForm DEFA14AUSAR · Form DEFA14A · 2026-08-24
USA Rare Earth Clears Key Merger Condition as U.S. Government Upsizes SPV Funding to $750M
ProForm 8-KUSAR · Form 8-K · 2026-08-24
FDA Finalizes Helix Catheter Meeting Minutes; BioCardia to Submit Follow-On Pre-Submission This Quarter
Form 8-KBCDA · Form 8-K · 2026-08-24
Arbutus Launches $230M Dutch Auction Tender at $5.00–$5.75/Share
Form SC TO-IABUS · Form SC TO-I · 2026-08-24
FDA Grants Fast Track Designation to Erasca's ERAS-0015 for Pancreatic Cancer
Form 8-KERAS · Form 8-K · 2026-08-24
Kimbell Closes $221.2M Dropdown, Raises 2026 Production Guidance 10-15%
ProForm 8-KKRP · Form 8-K · 2026-08-24
First Phosphate Files Updated MRE: Indicated Resources Jump 378% to 198.5 Mt
Form 6-KPHOS · Form 6-K · 2026-08-24
Jupiter Neurosciences Prices $2M Offering and Draws $851K More from Yorkville SEPA
Form 8-KJUNS · Form 8-K · 2026-08-24
Azenta CEO John Marotta Resigns; Board Director Dr. Martin Madaus Named Interim CEO
Form 8-KAZTA · Form 8-K · 2026-08-24
Jupiter Neurosciences Prices $2M Registered Direct Offering at $6.50/Share
Form 424B5JUNS · Form 424B5 · 2026-08-24
The9 Posts Record $32M Q2 Net Income, Yet Cash Dwindles to $1.9M and Impairments Reach $16.7M
ProForm 6-KNCTY · Form 6-K · 2026-08-24
Strive Adds 1,110 Bitcoin at $73,409 Average, Lifting Treasury to 21,356 BTC
Form 8-KASST · Form 8-K · 2026-08-24
Lithium Argentina Secures $180M Ganfeng Convertible Note at 96% Premium; Finalizes PPG Joint Venture
ProForm 6-KLAR · Form 6-K · 2026-08-24
RUM Group Signs $13.7B GPU Services Deal, Issues 50.8M-Share Warrant at $0.01
ProForm 8-KRUM · Form 8-K · 2026-08-24
Martin Marietta Closes $13.5B Lhoist North America Acquisition, Issues 10.95M Shares
ProForm 8-KMLM · Form 8-K · 2026-08-24
Gogoro Q2 Gross Margin Jumps to 22.6% as CFO Retires; New Principal Financial Officer Named
ProForm 6-KGGR · Form 6-K · 2026-08-24
Aurora Rebuts Curaleaf's Hostile Bid Claims, Reveals UK Acquisitions and German Market Strength
ProForm 6-KACB · Form 6-K · 2026-08-24
InterCure Finalizes NIS 230M (~US$77M) War-Damages Settlement
ProForm 6-KINCR · Form 6-K · 2026-08-24